MetaCap

LeMaitre Vascular Earnings

NASDAQ: LMATHealth CareMedical/Dental InstrumentsUSD

80.69+1.05 (+1.32%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

EPS estimate

$0.69

LeMaitre Vascular earnings summary

LeMaitre Vascular is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $0.69. In its most recent report on Aug 5, 2026 (Q2 2026), LMAT posted EPS of $0.74. Revenue for the quarter was $70.4 million.

Quarterly EPS is up 23.3% from the same quarter a year earlier. Across the last 16 reports, LMAT shares moved an average of 3.9% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

LMAT earnings history

LeMaitre Vascular reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 5, 2026—$0.74—+1.1%
May 6, 2026—$0.68—-9.8%
Feb 26, 2026—$0.69—-0.7%
Nov 7, 2025—$0.75—+1.9%
Aug 6, 2025—$0.60—+3.9%
May 8, 2025—$0.48—+5.6%
Feb 28, 2025—$0.48—-11.4%
Nov 8, 2024—$0.49—-2.1%
Aug 8, 2024—$0.52—+1.2%
May 10, 2024—$0.44—+3.0%
Feb 29, 2024—$0.38—-0.5%
Nov 7, 2023—$0.33—+9.4%
Aug 8, 2023—$0.36—-1.2%
May 9, 2023—$0.27—-4.5%
Mar 1, 2023—$0.25—-5.4%
Nov 8, 2022—$0.25—-0.9%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related